Respiratory Infections Flashcards
Streptococcus pneumoniae
Haemophilus influenzae
Moraxella catarrhalis
Typical bacteria
Mycoplasma pneumoniae
Chlamydophila pneumoniae
Atypical bacteria
Influenza, adenovirus, RSV, parainfluenza
Respiratory viruses
Typical bacteria presentaion
-High fever, productive cough, consolidated infiltrates, rapid onset
Atypical bacteria presentation
Mild fever, non-productive cough, diffuse or patchy infiltrates, slower onset
If use of antimicrobials within the previous 3 months………
AVOID same class antibiotics!!
Risk Factors for Drug Resistant
S. pneumoniae (DRSP)
Age >65 years β-lactam, macrolide, or fluoroquinolone therapy within the past 3 months Alcoholism Multiple medical comorbidities Immunosuppressive illness or therapy Exposure to a child in a day care
Previously healthy, no use of antimicrobials within past 3 months, outpatient CAP tx
Macrolide (azithromycin, clarithromycin)
OR
Doxycycline
Presence of comorbidities or previous antimicrobial use within past 3 months or risk factors for DRSP outpatient tx
Respiratory fluoroquinolone (moxifloxacin, gemifloxacin, levofloxacin)
OR
[Amoxicillin/clavulanate or cephalosporin] + macrolide
OR
[Amoxicillin/clavulanate or cephalosporin] + doxycycline
If Pseudomonas is suspected (based on comorbidities): COPD Structural lung disease Smoking outpatient tx
Levofloxacin (750 mg daily, high dose)
OR
Consider IV antipseudomonal β-lactam
Outpatient CAP if hx of alcoholism
Amoxicillin/clavulanate OR Cephalosporin + clindamycin OR Respiratory fluoroquinolone
Outpatient CAP if aspiration suspected
Amoxicillin/clavulanate OR Moxifloxacin OR Clindamycin
Drugs for pseudomonas coverage
Cefepime, zosyn, carbapenems
Drugs for MRSA coverage
Vancomycin or linezolid
HAP empiric tx
Should always cover MRSA & P. Aeruginosa & GNRs
-Pseudomonas & MRSA coverage
HAP empiric tx if prior IV abx use in last 90 days or high risk for mortality
- 2 anti-pseudomonal agents
- Cefepmie & tobramycin
- Pip/taxo & levofloxacin
- Do not use 2 beta lactams!!!
VAP organisms
- Staphylococcus aureus (20-30% of isolates)
- Pseudomonas aeruginosa (10-20% of isolates)
- Acinetobacter baumannii (5-10% of isolates) - very high resistance rates!!
Duration of therapy
8-15 days
Higher % of multidrbg-resistance seen with longer tx duration
Whooping cough
Persistent cough >14 days
Uncommon occurrence
High probability of exposure during outbreak
R/O asthma, GERD, Post-nasal drip
Antibiotic therapy aimed at eradicating nasal carriage
Bordetella pertussis
Bordetelle pertussis children tx
- Erythromycin estolate PO
- Erythromycin base PO
- Azithromycin
- Clarithromycin
- Isolate pt 5 days from start of tx!
Bordetella pertussis adult tx
- Azithromycin
- Erythromycin estolate
- Bactrim (TMP/SMX)
- Clarithromycin
- Isolate pt 5 days from start of tx!
Most common typical bacteria
H. Influenzae
Common viral pathogens
- Rhinovirus
- Influenza A & B
- Parainfluenza
- Coronavirus
- Respiratory syncytial virus (RSV)
- Adenovirus
Treatment of AECB
ABC approach
- Antibiotics
- Bronchodilators
- Corticosteroids
Antibiotic tx of AECB: simple chronic bronchitis
Macrolide (azithromycin, clarithromycin) OR 2nd or 3rd generation cephalosporin (cefuroxime, cefpodoxime, cefdinir) OR Doxycycline
Antibiotic tx of AECB: Complicated chronic bronchitis + comorbities
Respiratory fluoroquinolone (moxifloxacin, gemifloxacin, levofloxacin)
OR
Amoxicillin/clavulanate
OR
2nd or 3rd generation cephalosporin + doxycycline
Antibiotic tx of AECB: If at risk for pseudomonas
Levofloxacin
BM is a 47 year old male who has been diagnosed with chronic bronchitis. He reports having 3 exacerbations per year. He comes to your clinic with signs and symptoms consistent with an acute exacerbation.
What type of chronic bronchitis does this patient have?
What antibiotics would you prescribe?
Simple chronic bronchitis,
Macrolides or 2nd/3rd gen cephalosporin or doxycycline
Antigenic drift
Relatively minor change in genetic material
Enough change to require new vaccine every year
Generally short influenza season
Antigenic shift
Major change in genetic material
May lead to pandemic and high mortality
Generally prolonged or multi-wave influenza season